205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.12%
Revenue growth similar to INTC's 12.06%. Walter Schloss would see if both companies share industry tailwinds.
16.17%
Gross profit growth similar to INTC's 17.06%. Walter Schloss would assume both firms track common industry trends.
10.22%
EBIT growth below 50% of INTC's 33.95%. Michael Burry would suspect deeper competitive or cost structure issues.
12.17%
Operating income growth under 50% of INTC's 33.95%. Michael Burry would be concerned about deeper cost or sales issues.
13.43%
Net income growth under 50% of INTC's 44.58%. Michael Burry would suspect the firm is falling well behind a key competitor.
8.33%
EPS growth under 50% of INTC's 40.91%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
8.70%
Diluted EPS growth under 50% of INTC's 42.86%. Michael Burry would worry about an eroding competitive position or excessive dilution.
2.53%
Share count expansion well above INTC's 0.38%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.38%
Diluted share count expanding well above INTC's 0.36%. Michael Burry would fear significant dilution to existing owners' stakes.
0.49%
Dividend growth at 75-90% of INTC's 0.63%. Bill Ackman would press for a stronger return if the balance sheet allows.
83.58%
Positive OCF growth while INTC is negative. John Neff would see this as a clear operational advantage vs. the competitor.
152.78%
FCF growth above 1.5x INTC's 88.73%. David Dodd would verify if the firm’s strategic investments yield superior returns.
12.26%
10Y revenue/share CAGR under 50% of INTC's 574.66%. Michael Burry would suspect a lasting competitive disadvantage.
-16.56%
Negative 5Y CAGR while INTC stands at 164.65%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
101.94%
3Y revenue/share CAGR above 1.5x INTC's 45.95%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
153.21%
10Y OCF/share CAGR under 50% of INTC's 652.79%. Michael Burry would worry about a persistent underperformance in cash creation.
94.23%
Below 50% of INTC's 215.31%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
34.58%
3Y OCF/share CAGR above 1.5x INTC's 20.36%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
882.41%
Net income/share CAGR at 75-90% of INTC's 1163.09%. Bill Ackman would press for strategic moves to boost long-term earnings.
108.68%
Below 50% of INTC's 489.50%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
1537.14%
3Y net income/share CAGR above 1.5x INTC's 26.32%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
188.07%
Below 50% of INTC's 838.48%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
162.02%
5Y equity/share CAGR at 50-75% of INTC's 265.23%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
99.34%
3Y equity/share CAGR at 75-90% of INTC's 120.71%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
10.49%
Dividend/share CAGR of 10.49% while INTC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
27.18%
Below 50% of INTC's 316.12%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-6.24%
Negative near-term dividend growth while INTC invests at 179.16%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-5.96%
Firm’s AR is declining while INTC shows 5.90%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
18.73%
We show growth while INTC is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
13.87%
Similar asset growth to INTC's 12.61%. Walter Schloss finds parallel expansions or investment rates.
13.93%
1.25-1.5x INTC's 11.07%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-0.91%
We’re deleveraging while INTC stands at 13.07%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-3.71%
Our R&D shrinks while INTC invests at 4.40%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
28.49%
SG&A growth well above INTC's 16.07%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.